APA način citiranja

Harder, J., Ihorst, G., Heinemann, V., Hofheinz, R., Moehler, M., Buechler, P., . . . Geissler, M. (2012). Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer. Nature Publishing Group.

Čikaški stil citiranja

Harder, J., et al. Multicentre Phase II Trial of Trastuzumab and Capecitabine in Patients With HER2 Overexpressing Metastatic Pancreatic Cancer. Nature Publishing Group, 2012.

MLA način citiranja

Harder, J., et al. Multicentre Phase II Trial of Trastuzumab and Capecitabine in Patients With HER2 Overexpressing Metastatic Pancreatic Cancer. Nature Publishing Group, 2012.